mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.04 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.05 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.05 |
mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.05 |
mRNA |
nakiterpiosin |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.05 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.05 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.06 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.06 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.06 |